Skip to content

Safety and Performance of PEEK Anchors in Extremities

Safety and Performance of PEEK Anchors (DYNOMITE, SPYROMITE, RAPTOMITE, FOOTPRINT Ultra PK SL) in Extremities

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03782298
Enrollment
140
Registered
2018-12-20
Start date
2019-03-12
Completion date
2019-10-10
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Tendon Repairs/Reconstructions, Bicep Tendon Reattachments, Bunionectomy, Hallux Valgus Repairs, Lateral Epicondylitis Repair, Medial or Lateral Instability Repairs/Reconstructions, Metatarsal Ligament/Tendon Repairs/Reconstructions, Midfoot Reconstructions, Scapholunate Ligament Reconstructions, Ulnar

Keywords

Dynomite, Spyromite, Raptormite, Foot, Ankle, Wrist, Hand, Elbow, Footprint

Brief summary

Safety and performance of the study devices in extremities up to 12 months post-surgery

Interventions

DEVICESpyromite, Dynomite, Raptomite, Footprint Ultra PK SL

PEEK Suture Anchors, which include: * SPYROMITE™ 2.0 PK Suture Anchor with Needles * DYNOMITE™ 2.0 PK Suture Anchor with Needles * RAPTORMITE™ 3.0 Suture Anchor with Needles * FOOTPRINT™ Ultra PK SL Suture Anchor

Sponsors

Smith & Nephew, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects who have undergone extremity joint repair using the study devices. * Subjects aged 18 years and older at the time of surgery.

Exclusion criteria

* Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product within 12 months post-operative. * Subjects who are \< 3 months post-operative

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After Intervention6 monthsClinical success was defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon. Specifically, clinical success was considered Yes based on the following 3 main criteria: * no inflammatory or allergic response * no device-related adverse event (AE) * no device deficiencies (DDs) leading to revision surgery (re intervention) on the index extremity

Secondary

MeasureTime frameDescription
Number of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After Intervention12 monthsClinical success was defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon. Specifically, clinical success was considered Yes based on the following 3 main criteria: * no inflammatory or allergic response * no device-related adverse event (AE) * no device deficiencies (DDs) leading to revision surgery (reintervention) on the index extremity

Other

MeasureTime frameDescription
Visual Analog Scale (VAS) - Pain6 and 12 monthsThe VAS pain score is presented on a scale ranging from 0 to 10. A score of 0 represents no pain and a score of 10 indicates extreme/unbearable pain. The VAS rating was recorded retrospectively, per standard of care at 6 and 12 months post-surgery.
Count of Participants With Range of Motion (ROM) Full Functional Arc6 and 12 monthsRange of motion defined as the participant having a full functional arc Yes or No at 6 month and 12 month post-operative visits.

Countries

Canada, United States

Participant flow

Pre-assignment details

It was intended to enroll participants for 4 PEEK suture anchor devices; however, no participants were enrolled in the SPYROMITE™ 2.0 PK Suture Anchor with Needles group, resulting in 3 suture anchor groups being analyzed. A total of 140 participants were enrolled in the study and 142 joints were observed. Multiple devices were implanted in 2 participants. Separate arms not created as participants had the same procedure on the same joint. Anchors are shown by categories (rows) throughout.

Participants by arm

ArmCount
Polyetheretherketone (PEEK) Extremity Suture Anchors
Participants who have received Polyetheretherketone (PEEK) Extremity Suture Anchors, which included: DYNOMITE™ 2.0 PK Suture Anchor with Needles, RAPTORMITE™ 3.0 Suture Anchor with Needles, FOOTPRINT™ Ultra PK SL Suture Anchor
140
Polyetheretherketone (PEEK) Extremity Suture Anchors
Participants who have received Polyetheretherketone (PEEK) Extremity Suture Anchors, which included: DYNOMITE™ 2.0 PK Suture Anchor with Needles, RAPTORMITE™ 3.0 Suture Anchor with Needles, FOOTPRINT™ Ultra PK SL Suture Anchor
142
Total282

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProtocol Deviation4

Baseline characteristics

CharacteristicPolyetheretherketone (PEEK) Extremity Suture Anchors
Age, Continuous45 years
STANDARD_DEVIATION 13.6
Disposition of Suture Anchors
DYNOMITE™ 2.0 PK Suture Anchor with Needles
17 Participants
Disposition of Suture Anchors
FOOTPRINT™ Ultra PK SL Suture Anchor
57 Participants
Disposition of Suture Anchors
RAPTORMITE™ 3.0 PK Suture Anchor with Needles
71 Participants
Duration of Surgery (min)67 minutes
STANDARD_DEVIATION 28.5
Duration of time from injury to surgery (days)508.4 days
STANDARD_DEVIATION 994.7
Ethnicity (NIH/OMB)
Hispanic or Latino
6 joints
Ethnicity (NIH/OMB)
Not Hispanic or Latino
115 joints
Ethnicity (NIH/OMB)
Unknown or Not Reported
21 joints
Location of Device Implantation
Bilaterally
4 joints
Location of Device Implantation
Left
72 joints
Location of Device Implantation
Right
66 joints
Number of Joints Treated by Indication
Achilles tendon
54 joints
Number of Joints Treated by Indication
Medial instability
58 joints
Number of Joints Treated by Indication
Medial instability & Achilles tendon
1 joints
Number of Joints Treated by Indication
Medial instability & Other
5 joints
Number of Joints Treated by Indication
Metatarsal ligament
11 joints
Number of Joints Treated by Indication
Metatarsal ligament & Other
1 joints
Number of Joints Treated by Indication
Midfoot
2 joints
Number of Joints Treated by Indication
Midfoot & Metatarsal ligament
4 joints
Number of Joints Treated by Indication
Other
6 joints
Race/Ethnicity, Customized
American Indian or Alaska Native
No
142 joints
Race/Ethnicity, Customized
American Indian or Alaska Native
Yes
0 joints
Race/Ethnicity, Customized
Asian
No
142 joints
Race/Ethnicity, Customized
Asian
Yes
0 joints
Race/Ethnicity, Customized
Black or African American
No
137 joints
Race/Ethnicity, Customized
Black or African American
Yes
5 joints
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
No
142 joints
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
Yes
0 joints
Race/Ethnicity, Customized
Other
No
124 joints
Race/Ethnicity, Customized
Other
Yes
18 joints
Race/Ethnicity, Customized
White
No
22 joints
Race/Ethnicity, Customized
White
Yes
120 joints
Sex: Female, Male
Female
83 joints
Sex: Female, Male
Male
59 joints

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 170 / 710 / 57
other
Total, other adverse events
5 / 170 / 712 / 57
serious
Total, serious adverse events
0 / 172 / 712 / 57

Outcome results

Primary

Number of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After Intervention

Clinical success was defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon. Specifically, clinical success was considered Yes based on the following 3 main criteria: * no inflammatory or allergic response * no device-related adverse event (AE) * no device deficiencies (DDs) leading to revision surgery (re intervention) on the index extremity

Time frame: 6 months

Population: Participants analyzed at time frame specified for each row indicates participant provided retrospective data. Some participants implanted with multiple Suture Anchors (devices). Data analyzed independently based on specific device implanted (i.e., participants with multiple devices analyzed by unique suture anchor). Anchors shown by rows/categories as the same procedure occurred on the same joint. Overall number of participants analyzed shows combined total of distinct participants assessed.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After InterventionDYNOMITE™ 2.0 PK Suture Anchor with NeedlesYes16 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After InterventionDYNOMITE™ 2.0 PK Suture Anchor with NeedlesNo1 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After InterventionRAPTORMITE™ 3.0 PK Suture Anchor with NeedlesYes70 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After InterventionRAPTORMITE™ 3.0 PK Suture Anchor with NeedlesNo1 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After InterventionFOOTPRINT™ ULTRA PK SL SUTURE ANCHORYes57 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After InterventionFOOTPRINT™ ULTRA PK SL SUTURE ANCHORNo0 Participants
Secondary

Number of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After Intervention

Clinical success was defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon. Specifically, clinical success was considered Yes based on the following 3 main criteria: * no inflammatory or allergic response * no device-related adverse event (AE) * no device deficiencies (DDs) leading to revision surgery (reintervention) on the index extremity

Time frame: 12 months

Population: Participants analyzed at time frame specified for each row indicates participant provided retrospective data. Some participants implanted with multiple Suture Anchors (devices). Data analyzed independently based on specific device implanted (i.e., participants with multiple devices analyzed by unique suture anchor). Anchors shown by rows/categories as the same procedure occurred on the same joint. Overall number of participants analyzed shows combined total of distinct participants assessed.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After InterventionDYNOMITE™ 2.0 PK Suture Anchor With NeedlesYes2 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After InterventionDYNOMITE™ 2.0 PK Suture Anchor With NeedlesNo0 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After InterventionRAPTORMITE™ 3.0 Suture Anchor With NeedlesYes8 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After InterventionRAPTORMITE™ 3.0 Suture Anchor With NeedlesNo0 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After InterventionFOOTPRINT™ Ultra PK SL Suture AnchorYes16 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsNumber of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After InterventionFOOTPRINT™ Ultra PK SL Suture AnchorNo0 Participants
Other Pre-specified

Count of Participants With Range of Motion (ROM) Full Functional Arc

Range of motion defined as the participant having a full functional arc Yes or No at 6 month and 12 month post-operative visits.

Time frame: 6 and 12 months

Population: Participants analyzed at time frame specified for each row indicates participant provided retrospective data. Some participants implanted with multiple Suture Anchors (devices). Data analyzed independently based on specific device implanted (i.e., participants with multiple devices analyzed by unique suture anchor). Anchors shown by rows/categories as the same procedure occurred on the same joint. Overall number of participants analyzed shows combined total of distinct participants assessed.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcDYNOMITE™ 2.0 PK Suture Anchor With Needles: 6 monthsHas full functional arc: Yes3 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcDYNOMITE™ 2.0 PK Suture Anchor With Needles: 6 monthsHas full functional arc: No2 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcDYNOMITE™ 2.0 PK Suture Anchor With Needles: 6 monthsHas full functional arc: Unknown1 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcRAPTORMITE™ 3.0 Suture Anchor With Needles: 6 monthsHas full functional arc: Yes21 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcRAPTORMITE™ 3.0 Suture Anchor With Needles: 6 monthsHas full functional arc: No5 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcRAPTORMITE™ 3.0 Suture Anchor With Needles: 6 monthsHas full functional arc: Unknown29 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcRAPTORMITE™ 3.0 Suture Anchor With Needles: 12 monthsHas full functional arc: Yes1 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcRAPTORMITE™ 3.0 Suture Anchor With Needles: 12 monthsHas full functional arc: No2 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcRAPTORMITE™ 3.0 Suture Anchor With Needles: 12 monthsHas full functional arc: Unknown3 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcFOOTPRINT™ Ultra PK SL Suture Anchor: 6 monthsHas full functional arc: Yes34 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcFOOTPRINT™ Ultra PK SL Suture Anchor: 6 monthsHas full functional arc: No8 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcFOOTPRINT™ Ultra PK SL Suture Anchor: 6 monthsHas full functional arc: Unknown0 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcFOOTPRINT™ Ultra PK SL Suture Anchor: 12 monthsHas full functional arc: Yes11 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcFOOTPRINT™ Ultra PK SL Suture Anchor: 12 monthsHas full functional arc: No1 Participants
Polyetheretherketone (PEEK) Extremity Suture AnchorsCount of Participants With Range of Motion (ROM) Full Functional ArcFOOTPRINT™ Ultra PK SL Suture Anchor: 12 monthsHas full functional arc: Unknown0 Participants
Other Pre-specified

Visual Analog Scale (VAS) - Pain

The VAS pain score is presented on a scale ranging from 0 to 10. A score of 0 represents no pain and a score of 10 indicates extreme/unbearable pain. The VAS rating was recorded retrospectively, per standard of care at 6 and 12 months post-surgery.

Time frame: 6 and 12 months

Population: Participants analyzed at time frame specified for each row indicates participant provided retrospective data. Some participants implanted with multiple Suture Anchors (devices). Data analyzed independently based on specific device implanted (i.e., participants with multiple devices analyzed by unique suture anchor). Anchors shown by rows/categories as the same procedure occurred on the same joint. Overall number of participants analyzed shows combined total of distinct participants assessed.

ArmMeasureGroupValue (MEAN)Dispersion
Polyetheretherketone (PEEK) Extremity Suture AnchorsVisual Analog Scale (VAS) - PainDYNOMITE™ 2.0 PK Suture Anchor With Needles: 6 months2 score on a scale
Polyetheretherketone (PEEK) Extremity Suture AnchorsVisual Analog Scale (VAS) - PainRAPTORMITE™ 3.0 Suture Anchor With Needles: 6 months1.8 score on a scaleStandard Deviation 2.2
Polyetheretherketone (PEEK) Extremity Suture AnchorsVisual Analog Scale (VAS) - PainRAPTORMITE™ 3.0 Suture Anchor With Needles: 12 months3.7 score on a scaleStandard Deviation 4
Polyetheretherketone (PEEK) Extremity Suture AnchorsVisual Analog Scale (VAS) - PainFOOTPRINT™ Ultra PK SL Suture Anchor: 6 months2.6 score on a scaleStandard Deviation 2.5
Polyetheretherketone (PEEK) Extremity Suture AnchorsVisual Analog Scale (VAS) - PainFOOTPRINT™ Ultra PK SL Suture Anchor: 12 months2 score on a scaleStandard Deviation 2.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026